Product Program year 2025 Source: CMS Open Payments

Afinion 2

Device Rapid Diagnostics

PDI 07070060014708

Open in the dashboard

General payments

$175,775

196 payments

Research payments

$22,446

10 payments

Through program year 2025, $175,775 in general payments and $22,446 in research payments were reported against Afinion 2 (Rapid Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $44,912 98
2024 General $108,318 43
2024 Research $16,625 2
2023 General $22,545 55
2023 Research $5,821 8

Breakdown

Who paid General payments · program years 2023–2025
  1. Abbott Laboratories $175,775 196 payments
Top recipients General payments · program year 2025
  1. Olugbemiga Jegede Internal Medicine · Greensboro, NC $15,625 35% · 16 payments
  2. Aaron King Family Medicine · San Antonio, TX $7,520 17% · 13 payments
  3. Michael Kobernick Emergency Medicine · Warren, MI $6,820 15% · 5 payments
  4. Michael Fine Laguna Beach, CA $5,698 13% · 2 payments
  5. Eugene Wright Internal Medicine · Fayetteville, NC $2,500 6% · 1 payment

The top 5 of 55 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $20,571 52% · 9 practitioners
  2. Family Medicine $9,412 24% · 16 practitioners
  3. Emergency Medicine $6,820 17% · 1 practitioner
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $1,323 3% · 5 practitioners
  5. Nephrology Internal Medicine $400 1% · 1 practitioner

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $18,149 40% · 3 recipients
  2. Texas $10,279 23% · 19 recipients
  3. Michigan $6,820 15% · 1 recipient
  4. California $6,098 14% · 2 recipients
  5. Oregon $1,443 3% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

196 general · 10 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record